Solvay: agreement with Bioprojet on racecadotril

Solvay Pharmaceuticals, an international chemicals and pharmaceuticals group, has signed an agreement with Bioprojet, a French pharmaceutical company,to extend its gastroenterology portfolio to include racecadotril, a treatment for acute diarrhoea. The deal also covers Poland.

Solvay has registration agreements and exclusive distribution rights for a number of countries in Central and Eastern Europe (CEE), Russia and the Commonwealth of Independent States (CIS), Western Europe, Canada, South Africa and India, as well as other countries in Europe and Asia.
In addition to Poland, other CEE countries covered under the agreement are the Czech Republic, Slovakia, Estonia, Latvia, Lithuania, Hungary, Romania, Bulgaria and the Balkans. In Western Europe the markets included are Sweden, Finland, Norway, Denmark and Austria.

Source: PMR. For more info Pharmapoland.com